Rex Capital Advisors’s Chemours CC Stock Holding History

Rex Capital Advisors’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-9,963	Closed	-$220K	–	36
2016 Q4	$220K	Buy	+9,963	New	+$205K	0.21%	22
2016 Q2	–	Sell	-16,879	Closed	-$118K	–	26
2016 Q1	$118K	Hold	16,879	–	–	0.12%	34
2015 Q4	$90K	Sell	16,879 -8,882	-34%	-$56.8K	0.09%	34
2015 Q3	$167K	Buy	+25,761	New	+$270K	0.18%	39

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Rex Capital Advisors's CC Position: Q1 2017 in Review

Rex Capital Advisors sold out of Chemours (CC) in Q1 2017, closing a stake of 9,963 shares — an estimated $220K sold.

Rex Capital Advisors first reported a position in CC in Q3 2015 and held it in 4 quarters. The position peaked at $220K in Q4 2016. 458 funds tracked by Wall St. Rank hold CC as of Q1 2017.

Rex Capital Advisors reported no remaining Chemours position as of Q1 2017 after selling out during the quarter.
Rex Capital Advisors sold 9,963 Chemours shares in Q1 2017, an estimated $220K.
Rex Capital Advisors first reported a position in Chemours in Q3 2015 and held it in 4 quarters.
Rex Capital Advisors's Chemours position peaked at $220K in Q4 2016.
458 funds tracked by Wall St. Rank held Chemours as of Q1 2017.

Based on Rex Capital Advisors's 13F filing for Q1 2017, filed 12 May 2017.